Omega-3 fish oil shows promise against non-obese type 2 diabetes

A Brazilian study found that fish oil supplements reduced insulin resistance and inflammation in rats modeling non-obese type 2 diabetes. The research highlights a potential role for omega-3 fatty acids in cases where obesity is not a factor.

Researchers at institutions including the Butantan Institute gave Goto-Kakizaki rats fish oil three times a week for eight weeks. The dose equaled 2 grams per kilogram of body weight and contained specific amounts of EPA and DHA. Treated animals showed lower insulin resistance, improved blood sugar control, reduced inflammatory markers, and better cholesterol and triglyceride levels.

संबंधित लेख

Illustration of laboratory mice demonstrating effects of a sucrose-free diet on glucose tolerance and gut health.
AI द्वारा उत्पन्न छवि

Mice on sucrose-free low-fat diet showed impaired glucose control and gut inflammation, researchers report

AI द्वारा रिपोर्ट किया गया AI द्वारा उत्पन्न छवि तथ्य-जाँच किया गया

Eliminating sucrose from a low-fat diet worsened glucose tolerance and altered the gut microbiome in mice over 16 weeks, according to results presented on Saturday, June 13, 2026, at ENDO 2026, the Endocrine Society’s annual meeting in Chicago.

A two-year clinical trial has shown that high-dose omega-3 fish oil supplements do not improve memory or slow brain changes linked to Alzheimer's disease. The research involved 365 older adults at elevated risk for the condition. Results challenge widespread claims about the supplements' protective effects.

AI द्वारा रिपोर्ट किया गया

New research from Yale shows that oleic acid, the main fat in olive oil, accelerated tumor growth in mice prone to pancreatic cancer, while omega-3 fats from fish oil cut disease development by half.

A small clinical trial found that short periods of calorie restriction lowered inflammation markers tied to gum disease. Researchers at King's College London led the study involving patients in Spain. The results suggest dietary changes could complement standard dental treatments.

AI द्वारा रिपोर्ट किया गया

A new analysis of patient records shows that adults with type 2 diabetes who take GLP-1 receptor agonists face a higher rate of alopecia than those on other common diabetes medications.

यह वेबसाइट कुकीज़ का उपयोग करती है

हम अपनी साइट को बेहतर बनाने के लिए विश्लेषण के लिए कुकीज़ का उपयोग करते हैं। अधिक जानकारी के लिए हमारी गोपनीयता नीति पढ़ें।
अस्वीकार करें